Steris Applied Sterilization Technologies

Executive Summary

STERIS Applied Sterilization Technologies (STERIS AST) is a leading global contract sterilization and laboratory testing provider for the medical device and pharmaceutical industries. With a technology-neutral portfolio encompassing gamma, electron beam, X-ray, ethylene oxide, vaporized hydrogen peroxide, and steam sterilization, the company enables clients to meet stringent regulatory compliance for product safety. As a private entity valued at approximately $21.5 billion, STERIS AST benefits from the steady demand for sterile medical products and the trend toward outsourcing sterilization to specialized partners. Its comprehensive service model, including integrated equipment, dosimetry, and validation, positions it as a critical link in the healthcare supply chain. The company's established infrastructure and global footprint, particularly in Basingstoke, UK, support its ability to scale with market needs and maintain high service reliability.

Upcoming Catalysts (preview)

• Q2 2026Expansion of X-ray sterilization capacity85% success
• Q4 2026New ethylene oxide emissions compliance regulation70% success
• TBDStrategic partnership for pharmaceutical sterilization60% success